Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large Bcell Lymphoma

This book re-imagines the essence and role of adult education at both the individual and societal levels. It provides arguments for understanding adult education as a process of agency and empowerment, which has not only instrumental but intrinsic and transformative roles to play.

Increase Conversions And Engage Your Audience Through The Creation Of Stunning, Free And Professional-Looking Videos.

Validate your startup idea, build a list of waiting customers, and get paid, even if you have nothing to sell yet!

Validate your startup idea, build a list of waiting customers, and get paid, even if you have nothing to sell yet!

Editors: Haipeng Shao

Over the past few decades, lymphoma patient outcomes have improved as a result of multidrug chemotherapy and radiation therapy, intensification of treatment, improvement in supportive care, and better imaging and staging systems. Even more recently, there has been tremendous progress in the understanding of cancer cell biology and its microenvironment which has resulted in the development of biologic agents, also called "target" therapies. These therapies are more specific in targeting cancer cells either directly or via enhancement of the immune system. Many clinical studies have focused on biological agents in combination with traditional chemotherapy with the goal of improved outcomes, or reduced acute long term complications that are associated with lymphoma therapy.

by Daniele Bryden (Editor), Andrew Temple (Editor)